Summary of the Conference
Introduction of the Conference
Cardiology
Gastroenterology
Immunology & Inflammation
Molecular Biology & Genetics
Neuroscience
Tuberculosis EvolutionROCHE
Molecular and Tissue Diagnostics and Applied Science
Roche Molecular Diagnostics
Roche Molecular Diagnostics develops and manufactures innovative tests based on the Nobel Prize winning polymerase chain reaction (PCR) technology. PCR technology underlies a new generation of medical diagnostic tests that allow healthcare providers to select and monitor patient response to therapy or identify molecular characteristics of a disease. Roche Molecular Diagnostics’ blood-screening systems also help to ensure the safety of blood and blood products before they are used for medical procedures.
With its broad product portfolio of oncology, virology, microbiology and blood-screening tests, customers include researchers, physicians, patients, hospitals and laboratories worldwide.
Roche Applied Science
Roche Applied Science supplies a broad and growing range of instruments and highly specific reagents and test kits for use in the life science research market and for industrial applications. Its product portfolio and capabilities are especially strong in genomics and cellomics, sciences that are crucial for our understanding and the treatment of disease.
Roche Tissue Diagnostics
Ventana Medical Systems Inc., a member of the Roche group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s “Smart Systems” – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals.
Together with Roche, Ventana is driving personalised medicine through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies.
Homepages:
